Purchases and Sales Made in Q1 2023 in Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE) during Q1 2023. The information is specifically focused on institutions that hold shares of FATE THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-471K- 79.13% |
$2M - $5.24M
|
124K
$276K
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-472K- 26.15% |
$2M - $5.25M
|
1.33M
$2.96M
|
|
|
May 15, 2023
Q1 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-475K- 96.59% |
$2.01M - $5.28M
|
16.8K
$37.2K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-476K- 27.38% |
$2.02M - $5.29M
|
1.26M
$2.8M
|
|
|
May 15, 2023
Q1 2023
|
Gcm Grosvenor Holdings, LLC
Chicago, IL |
SELL
|
- |
-541K- 52.19% |
$2.3M - $6.02M
|
496K
$1.1M
|
|
|
May 02, 2023
Q1 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-750K- 98.65% |
$3.18M - $8.34M
|
10.2K
$22.7K
|
|
|
May 15, 2023
Q1 2023
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-750K- 60.0% |
$3.18M - $8.34M
|
500K
$1.11M
|
|
|
May 10, 2023
Q1 2023
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-866K- 85.45% |
$3.67M - $9.63M
|
147K
$327K
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.13M- 39.5% |
$4.8M - $12.6M
|
1.73M
$3.85M
|
|
|
May 15, 2023
Q1 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.16M- 43.59% |
$4.91M - $12.9M
|
1.5M
$3.33M
|